Abstract
This article discusses the conditions that may lead to a phenomenon called dysthyronemia. Here, the thyroid gland has concentration of thyrotropin in circulation within the reference range, but the concentrations of free or total fractions of thyroid hormones are outside the reference range. Normal values of thyrotropin (TSH) and increased values of THs are referred to as hyperthyroxinemia, while normal values of thyrotropin and decreased values of thyroid hormone are hypothyroxinemia. As shown by our observations, it is a relatively frequent situation in the parallel determinations of TSH and free thyroxine, when results verging on hyperthyroxinemia were found in 7% of cases (6.74%, n=259,590), and also in the parallel sets of TSH and total triiodothyronine when hypotriiodothyroninemia reached 8.5% (8.48%, n=73,143). We are assuming that the main cause of hyperthyroxinemia in the free thyroxine and TSH system is the presence of autoantibodies against thyroxine in patients with autoimmune thyroid disease. The reason of hypotriiodothyroninemia in the system of triiodothyronine and TSH is a decreased concentration of thyroid binding globulin in postmenopausal women. Manufacturers of immunoanalytical kits should take into account the potential adverse effects of autoantibodies against thyroid hormones when measuring the results of immunoassay determination of the free fraction of these hormones.
This work was funded by grant numbers NS/9837–4 and NT/12336–4 of the Internal Grant Agency, Czech Ministry of Health.
Conflict of interest statement: None declared
References
1. Bilek R, Starka L, Zamrazil V. Evaluation of dysthyronemia in endocrinological patients. Horm Mol Biol Clin Investig 2011;8:499–504.10.1515/HMBCI.2011.128Search in Google Scholar PubMed
2. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVolsi VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3–26.10.1089/105072503321086962Search in Google Scholar PubMed
3. Bartalena L, Bogazzi F, Brogioni S, Burelli A, Scarcello G, Martino E. Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction. Horm Res 1996;45:142–7.10.1159/000184777Search in Google Scholar PubMed
4. Fritz KS, Wilcox RB, Nelson JC. A direct free thyroxine (T4) immunoassay with the characteristics of a total T4 immunoassay. Clin Chem 2007;53:911–5.10.1373/clinchem.2006.083915Search in Google Scholar PubMed
5. Dumitrescu AM, Di Cosmo C, Liao XH, Weiss RE, Refetoff S. The syndrome of inherited partial SBP2 deficiency in humans. Antioxid Redox Signal 2010;12:905–20.10.1089/ars.2009.2892Search in Google Scholar PubMed PubMed Central
6. Dufour DR. Laboratory tests of thyroid function: uses and limitations. Endocrinol Metab Clin North Am 2007;36:579–94.10.1016/j.ecl.2007.04.003Search in Google Scholar PubMed
7. Almeida MR, Damas AM, Lans MC, Brouwer A, Saraiva MJ. Thyroxine binding to transthyretin Met 119: Comparative studies of different heterozygotic carriers and structural analysis. Endocrine 1997;6:309–15.10.1007/BF02820508Search in Google Scholar PubMed
8. Cartwright D, O’Shea P, Rajanayagam O, Agostini M, Barker P, Moran C, Macchia E, Pinchera A, John R, Agha A, Ross HA, Chatterjee VK, Halsall DJ. Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin Chem 2009;55:1044–6.10.1373/clinchem.2008.120303Search in Google Scholar PubMed
9. Hoshikawa S, Mori K, Kaise N, Nakagawa Y, Ito S, Yoshida K. Artifactually elevated serum-free thyroxine levels measured by equilibrium dialysis in a pregnant woman with familial dysalbuminemic hyperthyroxinemia. Thyroid 2004;14:155–60.10.1089/105072504322880409Search in Google Scholar PubMed
10. Petitpas I, Petersen CE, Ha CE, Bhattacharya AA, Zunszain PA, Ghuman J, Bhagavan NV, Curry S. Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc Natl Acad Sci USA 2003;100:6440–5.10.1073/pnas.1137188100Search in Google Scholar PubMed PubMed Central
11. Arevalo G. Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing. Clin Chem 1991;37:1430–1.10.1093/clinchem/37.8.1430Search in Google Scholar
12. Ando T, Yasui J, Inokuchi N, Usa T, Ashizawa K, Kamihara S, Eguchi K. Non-specific activities against ruthenium crosslinker as a new cause of assay interference in an electrochemilluminescent immunoassay. Intern Med 2007;46:1225–9.10.2169/internalmedicine.46.0188Search in Google Scholar PubMed
13. Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau IT, Ho H, Refetoff S. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab 1999;84:3919–28.Search in Google Scholar
14. Tjorve E, Tjorve KM, Olsen JO, Senum R, Oftebro H. On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses 2007;69:913–21.10.1016/j.mehy.2006.12.056Search in Google Scholar PubMed
15. Beck-Peccoz P, Piscitelli G, Amr S, Ballabio M, Bassetti M, Giannattasio G, Spada A, Nissim M, Weintraub BD, Faglia G. Endocrine biochemical and morphological studies of a pituitary adenoma secreting growth hormone TSH and alpha-subunit: evidence for secretion of TSH with increased bioactivity. J Clin Endocrinol Metab 1986;62:704–11.10.1210/jcem-62-4-704Search in Google Scholar PubMed
16. Donadio S, Pascual A, Thijssen JH, Ronin C. Feasibility study of new calibrators for TSH immunoprocedures based on remodeling of recombinant TSH to mimic glycoforms circulating in patients with thyroid disorders. Clin Chem 2006;52:286–97.10.1373/clinchem.2005.058172Search in Google Scholar PubMed
17. Hawkins RC. Furosemide interference in newer free thyroxine assays. Clin Chem 1998;44:2550–1.10.1093/clinchem/44.12.2550Search in Google Scholar
18. Jones AM, Honour JW. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol (Oxf) 2006;64:234–44.10.1111/j.1365-2265.2006.02439.xSearch in Google Scholar PubMed
19. Laji K, Rhidha B, John R, Lazarus J, Davies JS. Abnormal serum free thyroid hormone levels due to heparin administration. QJM 2001;94:471–3.10.1093/qjmed/94.9.471Search in Google Scholar PubMed
20. Stockigt JR, Lim CF. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab 2009;23:753–67.10.1016/j.beem.2009.06.004Search in Google Scholar PubMed
21. van der Watt G, Haarburger D, Berman P. Euthyroid patient with elevated serum free thyroxine. Clin Chem 2008;54:1239–41.10.1373/clinchem.2007.101428Search in Google Scholar PubMed
22. Perez CL, Araki FS, Graf H, Carvalho GA. Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid Jan 30 2013. [Epub ahead of print].10.1089/thy.2012.0435Search in Google Scholar PubMed
23. Reutrakul S, Dumitrescu A, Macchia PE, Moll GW Jr., Vierhapper H, Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency in two families without mutations in coding or promoter regions of the TBG genes: in vitro demonstration of exon skipping. J Clin Endocrinol Metab 2002;87:1045–51.10.1210/jcem.87.3.8275Search in Google Scholar PubMed
24. Zimmermann MB. Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. Am J Clin Nutr 2009;89:668S–72S.10.3945/ajcn.2008.26811CSearch in Google Scholar PubMed
25. Hieronimus S, Bec-Roche M, Ferrari P, Chevalier N, Fenichel P, Brucker-Davis F. [Iodine status and thyroid function of 330 pregnant women from Nice area assessed during the second part of pregnancy]. Ann Endocrinol (Paris) 2009;70:218–24.Search in Google Scholar
26. Nishiyama S, Mikeda T, Okada T, Nakamura K, Kotani T, Hishinuma A. Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake. Thyroid 2004;14:1077–83.10.1089/thy.2004.14.1077Search in Google Scholar PubMed
27. Vanderver GB, Engel A, Lamm S. Cigarette smoking and iodine as hypothyroxinemic stressors in U.S. women of childbearing age: a NHANES III analysis. Thyroid 2007;17:741–6.10.1089/thy.2006.0332Search in Google Scholar PubMed
28. Zhou Q, Li S, Li X, Wang W, Wang Z. Comparability of five analytical systems for the determination of triiodothyronine, thyroxine and thyroid-stimulating hormone. Clin Chem Lab Med 2006;44:1363–6.10.1515/CCLM.2006.251Search in Google Scholar PubMed
29. Sakata S, Matsuda M, Ogawa T, Takuno H, Matsui I, Sarui H, Yasuda K. Prevalence of thyroid hormone autoantibodies in healthy subjects. Clin Endocrinol (Oxf) 1994;41:365–70.10.1111/j.1365-2265.1994.tb02558.xSearch in Google Scholar PubMed
30. Vyas SK, Wilkin TJ. Thyroid hormone autoantibodies and their implications for free thyroid hormone measurement. J Endocrinol Invest 1994;17:15–21.10.1007/BF03344956Search in Google Scholar PubMed
31. Després N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 1998;44:440–54.10.1093/clinchem/44.3.440Search in Google Scholar
32. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942–56.10.1093/clinchem/45.7.942Search in Google Scholar
33. Vaidya HC, Beatty BG. Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab’)2 conjugate and polyclonal mouse IgG. Clin Chem 1992;38:1737–42.10.1093/clinchem/38.9.1737Search in Google Scholar
©2013 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Mini Review
- Dysthyronemia in normal concentrations of thyrotropin – analytical and clinical consequences
- Original Article
- Hormone replacement therapy: evolution of body mass index, bone mineral density, and lipid profile
Articles in the same Issue
- Mini Review
- Dysthyronemia in normal concentrations of thyrotropin – analytical and clinical consequences
- Original Article
- Hormone replacement therapy: evolution of body mass index, bone mineral density, and lipid profile